文献速递免疫规划妇幼与学校卫生

老挝人民民主共和国医疗机构中母亲与脐带血抗破伤风抗体血清流行率及相关因素

Seroprevalence of anti-tetanus antibodies in mothers and cord blood and associated factors in health-care settings in Lao People's Democratic Republic.
PubMed 文献 · Vaccine · 2019-11-14

在老挝沙湾拿吉省三家地区医院招募185名分娩孕妇,用问卷和ELISA检测母亲及脐带血抗破伤风抗体。77%母亲和79%新生儿抗体达保护水平(>0.5 IU/ml),但仅45%母亲接受推荐的两剂破伤风疫苗接种。结论认为血清流行率中等而TT2+覆盖率低,需促进首次产检接种并考虑4-7岁儿童加强剂。

要点

  • 77%母亲和79%新生儿抗破伤风抗体达保护水平(>0.5 IU/ml)。
  • 仅70%母亲在产检时接种一剂破伤风疫苗,45%接受推荐的两剂。
  • 作者建议促进首次产检疫苗宣传与接种,并考虑4-7岁儿童加强剂。

核心结论

  • 老挝医疗机构中母亲和新生儿抗破伤风抗体血清流行率中等,但TT2+覆盖率低。
  • 产检实践不健全的地区TT2+覆盖率可能显著更低,首次和第二次产检存在漏种机会。
  • 作者建议促进首次产检的疫苗认识和接种,并考虑4-7岁儿童接种含破伤风类毒素疫苗加强剂。

研究设计与样本

  • 在老挝沙湾拿吉省三家地区医院招募185名分娩孕妇。
  • 问卷调查确定与血清保护相关的因素,并用ELISA检测母亲和脐带血抗破伤风抗体。

主要发现

  • 77%母亲和79%新生儿抗破伤风抗体滴度>0.5 IU/ml,达到充分保护水平。
  • 仅70%母亲在产前保健咨询时接种一剂破伤风疫苗,45%接受推荐的两剂注射。
  • 多数接种发生在第一次和第二次产检时,但许多接种在这些时间点被遗漏。
  • 母亲抗破伤风血清保护与母亲年龄、产检次数、孕期及孕前破伤风疫苗接种次数和孕周相关。

关键数值与推荐

  • WHO建议孕期2剂及以上破伤风疫苗接种(TT2+)覆盖率达80%以维持母亲新生儿破伤风控制。
  • 血清保护定义为抗破伤风抗体滴度>0.5 IU/ml。

临床怎么用

  • 作者认为产检中第一次和第二次产检的漏种机会提示需促进首次产检的疫苗认识和接种。
  • 作者建议考虑4-7岁儿童接种含破伤风类毒素疫苗加强剂。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal neonatal tetanus (MNT) was eliminated from Lao People's Democratic Republic (PDR) in 2014. WHO recommends 80% coverage of 2 or more tetanus vaccinations (TT2+) in pregnancy to maintain MNT control. Vaccination coverage in Lao PDR varies among regions although the reasons are not clear. METHODS: 185 pregnant women giving birth in three district hospitals in Savannakhet province, Lao PDR were recruited. A questionnaire was administered to determine factors associated with seroprotection and blood was taken from mother and cord blood to be tested for anti-tetanus antibodies by ELISA. RESULTS: 77% of mothers and 79% of newborns had sufficiently protective antibody titres (>0.5 IU/ml) against tetanus. Only 70% of the mothers received one dose of TT vaccination during antenatal care (ANC) consultation and 45% received the recommended two injections. Although most of the vaccination took place during ANC 1 and 2, many were missed at these time-points. Anti-tetanus seroprotection in the mothers was associated with maternal age, number of ANC visits, number of TT vaccinations during and before pregnancy and gestational age. CONCLUSION: Seroprevalence of anti-tetanus antibodies in mothers and newborns was intermediate but TT2+ coverage was low in healthcare settings in Lao PDR. TT2+ coverage during ANC is likely to be significantly lower in settings with less robust ANC practices. Missed opportunities to vaccinate in ANC 1 and 2 suggest a need to promote vaccine awareness and vaccination at first ANC visit. A booster dose of TT containing vaccine should be considered for children aged between 4 and 7 years old.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ounnavong P, Chanthavilay P, Khampanisong P, et al. Seroprevalence of anti-tetanus antibodies in mothers and cord blood and associated factors in health-care settings in Lao People's Democratic Republic. Vaccine. 2019. PMID: 31735506. doi:10.1016/j.vaccine.2019.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。